Cargando…

Multiscale modelling of drug transport and metabolism in liver spheroids

In early preclinical drug development, potential candidates are tested in the laboratory using isolated cells. These in vitro experiments traditionally involve cells cultured in a two-dimensional monolayer environment. However, cells cultured in three-dimensional spheroid systems have been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Leedale, Joseph A., Kyffin, Jonathan A., Harding, Amy L., Colley, Helen E., Murdoch, Craig, Sharma, Parveen, Williams, Dominic P., Webb, Steven D., Bearon, Rachel N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061947/
https://www.ncbi.nlm.nih.gov/pubmed/32194929
http://dx.doi.org/10.1098/rsfs.2019.0041
_version_ 1783504467498369024
author Leedale, Joseph A.
Kyffin, Jonathan A.
Harding, Amy L.
Colley, Helen E.
Murdoch, Craig
Sharma, Parveen
Williams, Dominic P.
Webb, Steven D.
Bearon, Rachel N.
author_facet Leedale, Joseph A.
Kyffin, Jonathan A.
Harding, Amy L.
Colley, Helen E.
Murdoch, Craig
Sharma, Parveen
Williams, Dominic P.
Webb, Steven D.
Bearon, Rachel N.
author_sort Leedale, Joseph A.
collection PubMed
description In early preclinical drug development, potential candidates are tested in the laboratory using isolated cells. These in vitro experiments traditionally involve cells cultured in a two-dimensional monolayer environment. However, cells cultured in three-dimensional spheroid systems have been shown to more closely resemble the functionality and morphology of cells in vivo. While the increasing usage of hepatic spheroid cultures allows for more relevant experimentation in a more realistic biological environment, the underlying physical processes of drug transport, uptake and metabolism contributing to the spatial distribution of drugs in these spheroids remain poorly understood. The development of a multiscale mathematical modelling framework describing the spatio-temporal dynamics of drugs in multicellular environments enables mechanistic insight into the behaviour of these systems. Here, our analysis of cell membrane permeation and porosity throughout the spheroid reveals the impact of these properties on drug penetration, with maximal disparity between zonal metabolism rates occurring for drugs of intermediate lipophilicity. Our research shows how mathematical models can be used to simulate the activity and transport of drugs in hepatic spheroids and in principle any organoid, with the ultimate aim of better informing experimentalists on how to regulate dosing and culture conditions to more effectively optimize drug delivery.
format Online
Article
Text
id pubmed-7061947
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-70619472020-03-19 Multiscale modelling of drug transport and metabolism in liver spheroids Leedale, Joseph A. Kyffin, Jonathan A. Harding, Amy L. Colley, Helen E. Murdoch, Craig Sharma, Parveen Williams, Dominic P. Webb, Steven D. Bearon, Rachel N. Interface Focus Articles In early preclinical drug development, potential candidates are tested in the laboratory using isolated cells. These in vitro experiments traditionally involve cells cultured in a two-dimensional monolayer environment. However, cells cultured in three-dimensional spheroid systems have been shown to more closely resemble the functionality and morphology of cells in vivo. While the increasing usage of hepatic spheroid cultures allows for more relevant experimentation in a more realistic biological environment, the underlying physical processes of drug transport, uptake and metabolism contributing to the spatial distribution of drugs in these spheroids remain poorly understood. The development of a multiscale mathematical modelling framework describing the spatio-temporal dynamics of drugs in multicellular environments enables mechanistic insight into the behaviour of these systems. Here, our analysis of cell membrane permeation and porosity throughout the spheroid reveals the impact of these properties on drug penetration, with maximal disparity between zonal metabolism rates occurring for drugs of intermediate lipophilicity. Our research shows how mathematical models can be used to simulate the activity and transport of drugs in hepatic spheroids and in principle any organoid, with the ultimate aim of better informing experimentalists on how to regulate dosing and culture conditions to more effectively optimize drug delivery. The Royal Society 2020-04-06 2020-02-14 /pmc/articles/PMC7061947/ /pubmed/32194929 http://dx.doi.org/10.1098/rsfs.2019.0041 Text en © 2020 The Authors. http://creativecommons.org/licenses/by/4.0/ Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Articles
Leedale, Joseph A.
Kyffin, Jonathan A.
Harding, Amy L.
Colley, Helen E.
Murdoch, Craig
Sharma, Parveen
Williams, Dominic P.
Webb, Steven D.
Bearon, Rachel N.
Multiscale modelling of drug transport and metabolism in liver spheroids
title Multiscale modelling of drug transport and metabolism in liver spheroids
title_full Multiscale modelling of drug transport and metabolism in liver spheroids
title_fullStr Multiscale modelling of drug transport and metabolism in liver spheroids
title_full_unstemmed Multiscale modelling of drug transport and metabolism in liver spheroids
title_short Multiscale modelling of drug transport and metabolism in liver spheroids
title_sort multiscale modelling of drug transport and metabolism in liver spheroids
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061947/
https://www.ncbi.nlm.nih.gov/pubmed/32194929
http://dx.doi.org/10.1098/rsfs.2019.0041
work_keys_str_mv AT leedalejosepha multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT kyffinjonathana multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT hardingamyl multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT colleyhelene multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT murdochcraig multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT sharmaparveen multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT williamsdominicp multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT webbstevend multiscalemodellingofdrugtransportandmetabolisminliverspheroids
AT bearonracheln multiscalemodellingofdrugtransportandmetabolisminliverspheroids